Posts in category

Products


Professor Michelle Leech, Head of the Rheumatoid Arthritis Clinic at Monash Health, Victoria, explains the importance of bolstering patient confidence through collaborative care. Displaying this combined physician and pharmacist approach …

George Tambassis, Pharmacist, ex-National Guild President, and chair of the Australian Biosimilar Academy Advisory Board outlines the importance of pharmacist involvement in understanding biosimilars. Given the government supported Community Pharmacy …

In this video, Professor Andrew McLachlan discusses how a patient’s health literacy can impact their choice of self-management strategies for OA symptoms and how a lack of condition awareness can …

A recent study found only 3.5% of participants with self-reported OA symptoms sought advice from a pharmacist despite the critical role pharmacists play in helping patients on their pain management …

Presenter: Melanie McGrice Melanie McGrice, an Australian Dietitian with a special interest in fertility, speaks to AJP’s Miranda Deakin about the importance of evidence-based nutrition during preconception and pregnancy. After …

Presenter: Melanie McGrice Melanie McGrice, an Australian Dietitian with a special interest in fertility, speaks to AJPs Miranda Deakin about the importance of evidence-based nutrition during preconception and pregnancy. After …

Perspectives from Pharmacist and Credentialled Diabetes Educator (CDE), Melina Tandy Starting on insulin can be a daunting experience for many patients with diabetes. Pharmacists can provide key guidance and care …

Growing use of biosimilar medicines Biosimilar medicines have been approved for use in Australia since 20101 and are now supported by more than 15 years of real-world clinical experience. 6,7 …

Transitioning Patients to OPTISULIN® (insulin glargine 100 units/mL) from LANTUS® (insulin glargine 100 units/mL) Optisulin® is the second brand of insulin glargine 100 units/mL from Sanofi1, the manufacturer of Lantus2. …